Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
615.60B
Market cap615.60B
Price-Earnings ratio
39.34
Price-Earnings ratio39.34
Dividend yield
2.04%
Dividend yield2.04%
Average volume
8.19M
Average volume8.19M
High today
$257.86
High today$257.86
Low today
$255.12
Low today$255.12
Open price
$257.40
Open price$257.40
Volume
915.65K
Volume915.65K
52 Week high
$281.07
52 Week high$281.07
52 Week low
$184.66
52 Week low$184.66

Stock Snapshot

With a market cap of 615.6B, Johnson & Johnson(JNJ) trades at $255.45. The stock has a price-to-earnings ratio of 39.34 and currently yields dividends of 2.04%.

As of 2026-10-21, Johnson & Johnson(JNJ) stock has fluctuated between $255.12 and $257.86. The current price stands at $255.45, placing the stock +0.1% above today's low and -0.9% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 915.65K, compared to an average daily volume of 8.19M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.

JNJ News

New York Times 3h
After a Packers rout shook the Bears, Ben Johnson challenged his team. They answered - The Athletic - The New York Times

...

After a Packers rout shook the Bears, Ben Johnson challenged his team. They answered - The Athletic - The New York Times
TipRanks 4h
Johnson & Johnson downgraded to Hold from Buy at Erste Group

Erste Group downgraded Johnson & Johnson to Hold from Buy. On a sector-by-sector basis, the stock is trading at a high valuation, which leads the firm to believ...

The Wall Street Journal 5h
Healthcare Stocks Are Rallying, and Flashing a Warning for the Rest of the Market

Johnson & Johnson is forecasting double-digit sales growth by the end of the decade. Jeff Schear / Johnson & Johnson / Getty Images Healthcare stocks no longer...

Healthcare Stocks Are Rallying, and Flashing a Warning for the Rest of the Market

Analyst ratings

70%

of 27 ratings
Buy
70.4%
Hold
22.2%
Sell
7.4%

More JNJ News

TipRanks 23h
Johnson & Johnson: Buy Rating Reiterated on Underappreciated Pharma and MedTech Growth, $300 Price Target Unchanged

Analyst Michael Nedelcovych from TD Cowen maintained a Buy rating on Johnson & Johnson and keeping the price target at $300.00. Michael Nedelcovych has given hi...

Simply Wall St 24h
Johnson & Johnson Stock Looks Reasonable As Crohns Drug Data Lands

has delivered a powerful multi year run in its share price, which puts a fresh spotlight on whether the current market value lines up with the cash the business...

Johnson & Johnson Stock Looks Reasonable As Crohns Drug Data Lands
Zacks 1d
Healthcare ETFs to Buy as JNJ Slips 6% Despite Q3 Earnings Beat

Shares of Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) initially dropped nearly 6% on Oct. 13, after announcing third-quarter 2026 results. Althou...

Healthcare ETFs to Buy as JNJ Slips 6% Despite Q3 Earnings Beat
TipRanks 1d
Johnson & Johnson announces U.S. launch of Shockwave C2 Aero Fly catheter

Johnson & Johnson announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL Catheter designed to treat a broad range of calcified coronary artery lesi...

Zacks 1d
The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services

Chicago, IL – October 20, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the l...

The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services
The Wall Street Journal 1d
Health Care Roundup: Market Talk

george frey / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Health Care Roundup: Market Talk
24/7 Wall St. 2d
Ds vs. Dividend Stocks: One Protects Your Principal, the Other Could Grow Your Income

Investing Ds vs. Dividend Stocks: One Protects Your Principal, the Other Could Grow Your Income A CD and a dividend stock can both pay you income in retirement,...

Ds vs. Dividend Stocks: One Protects Your Principal, the Other Could Grow Your Income

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.